0001209191-19-055410.txt : 20191105
0001209191-19-055410.hdr.sgml : 20191105
20191105212748
ACCESSION NUMBER: 0001209191-19-055410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191024
FILED AS OF DATE: 20191105
DATE AS OF CHANGE: 20191105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leproust Emily M.
CENTRAL INDEX KEY: 0001753655
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 191194892
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-24
0
0001581280
Twist Bioscience Corp
TWST
0001753655
Leproust Emily M.
C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
1
1
0
0
President & CEO
Common Stock
2019-10-24
4
A
0
30630
0.00
A
856191
D
Employee Stock Option (right to buy)
23.33
2019-10-24
4
A
0
131290
0.00
A
2029-10-23
Common Stock
131290
131290
D
Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
2019-11-05